drugset / Trial / NCT01327027

Vasopressin Effects on Human Social Communication

NCT01327027

RandomizedCrossoverDouble-blindBasic science

Summary

This research is being done because we wish to understand how a chemical produced in the brain, vasopressin, effects emotional social communication processes. Understanding how this system works in normal individuals may help us understand why some people, particularly those with autism and/or antisocial personality disorder, have dysfunctional social interactions. This study will test the effects of 3 doses of arginine vasopressin, delivered intranasally, on physiological and behavioral responses to the faces of same- and other-sex individuals in healthy men and women.

Timeline

Start
2011-09
Primary completion
2015-12
Completion
2017-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Vasopressin Peptide 20 iu Intranasal
Subject Vasopressin Peptide 40 iu Intranasal

Indications

No indication recorded.